Annual Drug Patent Expirations for RESTASIS
Restasis is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.
Drug patent litigation for RESTASIS.
This drug has one patent family member in one country.
The generic ingredient in RESTASIS is cyclosporine. Two suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com